XML 48 R39.htm IDEA: XBRL DOCUMENT v3.25.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Taxes
U.S. and foreign (loss) earnings from continuing operations before income taxes and noncontrolling interests are as follows:
 Year Ended December 31,
 202420232022
 (In thousands)
U.S. $(731,333)$389,591 $(1,188,768)
Foreign16,294 3,438 (198,904)
     Total$(715,039)$393,029 $(1,387,672)
Schedule of Components of Income Tax Expense (Benefit)
The components of the income tax provision (benefit) are as follows:
 Year Ended December 31,
 202420232022
 (In thousands)
Current income tax provision:   
Federal$1,796 $1,411 $750 
State4,824 6,071 2,071 
Foreign8,168 2,277 (509)
Current income tax provision14,788 9,759 2,312 
Deferred income tax (benefit) provision:   
Federal(134,703)79,801 (228,908)
State(22,060)8,625 (42,085)
Foreign104 (23)(42,582)
     Deferred income tax (benefit) provision(156,659)88,403 (313,575)
     Income tax (benefit) provision$(141,871)$98,162 $(311,263)
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the income tax (benefit) provision to the amounts computed by applying the statutory federal income tax rate to earnings from continuing operations before income taxes is shown as follows:
 Year Ended December 31,
 202420232022
 (In thousands)
Income tax (benefit) provision at the federal statutory rate of 21% $(150,158)$82,536 $(291,411)
State income taxes, net of effect of federal tax benefit(16,638)9,385 (24,824)
Non-deductible portion of goodwill in the sale of Mosaic23,839 — — 
Non-deductible executive compensation8,170 6,869 7,628 
Change in valuation allowance on capital losses(8,720)(5,110)10,010 
Research credit(6,576)(7,142)(10,395)
Non-deductible goodwill impairment— 1,659 15,764 
Deferred tax adjustment for enacted changes in tax laws and rates154 308 (7,330)
Change in judgement on beginning of the year valuation allowance— (240)2,557 
Other, net8,058 9,897 (13,262)
     Income tax (benefit) provision$(141,871)$98,162 $(311,263)
Schedule of Deferred Tax Assets and Liabilities
The tax effects of cumulative temporary differences that give rise to significant deferred tax assets and deferred tax liabilities are presented below. The valuation allowance relates to deferred tax assets for which it is more likely than not that the tax benefit will not be realized.
 December 31,
 20242023
 (In thousands)
Deferred tax assets:  
Net operating loss carryforwards$227,708 $267,666 
Capitalized research & development expenditures91,187 71,979 
Long-term lease liabilities85,916 94,904 
Tax credit carryforwards44,991 43,833 
Accrued expenses43,130 41,392 
Stock-based compensation36,285 31,120 
Other37,845 51,057 
Total deferred tax assets567,062 601,951 
Less: valuation allowance(62,629)(61,569)
Total deferred tax assets, net of valuation allowance504,433 540,382 
Deferred tax liabilities:  
Investment in MGM Resorts International(229,597)(378,112)
Investment in subsidiaries(222,904)(223,903)
Intangible assets, net of accumulated amortization(111,654)(127,454)
Right-of-use assets(53,989)(60,317)
Other(38,342)(41,737)
Total deferred tax liabilities(656,486)(831,523)
Net deferred tax liabilities$(152,053)$(291,141)
Schedule of Unrecognized Tax Benefits Roll Forward
A reconciliation of the beginning and ending amount of unrecognized tax benefits, including penalties but excluding interest, is as follows:
 Year Ended December 31,
 202420232022
 (In thousands)
Balance at January 1$11,275 $9,843 $10,951 
Additions for tax positions related to the current year2,786 3,381 3,466 
Settlements— (2,265)(4,133)
Additions for tax positions of prior years— 622 1,167 
Reductions for tax positions of prior years(202)(306)(1,608)
Balance at December 31$13,859 $11,275 $9,843